Zobrazeno 1 - 10
of 36
pro vyhledávání: '"R Bisoendial"'
Autor:
Dominique Baeten, Patrick S. Asmawidjaja, Johanna M. W. Hazes, R Bisoendial, X Xu, Erik Lubberts, Anne-Marie Mus, Errol P. Prens, Nadine Davelaar, Marijn Vis
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & rheumatology (Hoboken, N.J.), 72(8), 1303-1313. John Wiley and Sons Ltd
Arthritis and Rheumatology, 72(8), 1303-1313. John Wiley & Sons Ltd.
Arthritis & rheumatology (Hoboken, N.J.), 72(8), 1303-1313. John Wiley and Sons Ltd
Arthritis and Rheumatology, 72(8), 1303-1313. John Wiley & Sons Ltd.
Objective: Interleukin-17A (IL-17A) and tumor necrosis factor (TNF) contribute to the pathogenesis of psoriatic arthritis (PsA). However, their functional relationship in PsA synovitis has not been fully elucidated. Additionally, although CD8+ T cell
Autor:
C. Pineda, T. Korotaeva, B. Moeller, T. Gudu, R. Bisoendial, S. Grazio, Oliver FitzGerald, Eric Ruderman, R. Perez Alamino, S. Rohekar, S. Juhl Pedersen, L. Candia, H. Raffayova, Wilson Bautista-Molano, Girish M. Mody, W. Olsder, Ying Ying Leung
Publikováno v:
Annals of the Rheumatic Diseases. 80:1296-1297
Background:Much new information has been reported since the last evidence-based GRAPPA recommendations for the treatment of psoriasis and psoriatic arthritis (PsA).Objectives:We aimed to compile the evidence for the efficacy and safety of established
Autor:
Alwin J. van der Ham, Lathees Sritharan, Willianne Hoepel, Jeroen den Dunnen, Dominique Baeten, Leonie de Boer, Melissa Newling, Bart Everts, Sebastian A. J. Zaat, R Bisoendial, Renée H. Fiechter
Publikováno v:
Journal of Immunology, 203(1), 225-235. AMER ASSOC IMMUNOLOGISTS
Journal of immunology (Baltimore, Md., 203(1), 225-235. American Association of Immunologists
Journal of immunology (Baltimore, Md., 203(1), 225-235. American Association of Immunologists
C-reactive protein (CRP) is an acute-phase protein produced in high quantities by the liver in response to infection and during chronic inflammatory disorders. Although CRP is known to facilitate the clearance of cell debris and bacteria by phagocyti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d2ed83a81c3ff564aaecdb7876ea86
https://hdl.handle.net/1887/122194
https://hdl.handle.net/1887/122194
Autor:
Erik Lubberts, A-M Otten-Mus, J. M. W. Hazes, Nadine Davelaar, Marijn Vis, X Xu, Dominique Baeten, Patrick S. Asmawidjaja, R Bisoendial
Publikováno v:
Abstracts.
Career situation of first and presenting author Student for a master or a PhD. Introduction Interleukin-17A (IL-17A) contributes to the pathogenesis of psoriatic arthritis (PsA) as evidenced by the success of biologics targeting IL-17 pathway in PsA
Autor:
J. M. W. Hazes, R Bisoendial, Patrick S. Asmawidjaja, X Xu, Marijn Vis, Dominique Baeten, Erik Lubberts, A-M Otten-Mus, Nadine Davelaar
Publikováno v:
Poster presentations.
Introduction TNF and IL-17A are proinflammatory cytokines critically involved in the pathogenesis of psoriatic arthritis (PsA). Currently, targeting TNF is the first choice of a biologic disease-modifying antirheumatic drug (bDMARD) in PsA. However,
Autor:
Johanna M. W. Hazes, Nadine Davelaar, Marijn Vis, A-M Otten-Mus, H Alves, J. P. van Hamburg, H. den Braanker, Erik Lubberts, R Bisoendial, Patrick S. Asmawidjaja, X Xu, Corine Gaillez, Frank Kolbinger
Publikováno v:
Abstracts Accepted for Publication.
Background Interleukin (IL)-17A is a pro-inflammatory cytokine and is involved in the pathogenesis of psoriatic arthritis (PsA) (1,2). Various cells can produce IL-17A. However, it is not clear which cell types in PsA patients are responsible for the
Autor:
Nadine Davelaar, PS Asmawidjaja, Johanna Mw Hazes, R Bisoendial, Arien Hofman, E Lubberts, Errol P. Prens, Adriana M.C. Mus, Marc R. Kok, Jean-Bart Jaquet
Publikováno v:
Abstracts Accepted for Publication.
Background The factors underlying the transition of psoriasis (PsO) to psoriatic arthritis (PsA) are poorly understood. The lymphatic system may control the homing of disease-associated T-cells to skin and extra-cutaneous sites like synovial joints a
Autor:
Matthias Laudes, Aart C. Strang, Paul P. Tak, R. Bisoendial, Erik S.G. Stroes, Marc R. Kok, Uwe J. F. Tietge, Ruud S. Kootte, Dominik M. Schulte, Johannes H.M. Levels, Danielle M. Gerlag, Sander W. Tas, N Müller, Geesje M. Dallinga-Thie, Koen Vos
Publikováno v:
Atherosclerosis, 229(1), 174-181. Elsevier Ireland Ltd
ATHEROSCLEROSIS, 229(1), 174-181. ELSEVIER IRELAND LTD
ATHEROSCLEROSIS, 229(1), 174-181. ELSEVIER IRELAND LTD
Objectives: Blocking the interleukin-6 pathway by tocilizumab (TCZ) has been associated with changes in the lipoprotein profile, which could adversely impact cardiovascular (CV) risk in patients with rheumatoid arthritis (RA). In the present study, w
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kerry-Anne Rye, Elias N. Glaros, Liming Hou, Blake J. Cochran, Shane R. Thomas, R. Bisoendial, Philip J. Barter, Jérémie Rossy
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 34(10)
Objective— Therapeutic interventions that increase plasma levels of high-density lipoproteins and apolipoprotein A-I (apoA-I) A-I, the major high-density lipoprotein apolipoprotein, improve glycemic control in people with type 2 diabetes mellitus.